SIAIS001
SIAIS001 is a CRBN-dependent ALK PROTAC degrader with a DC50 of 3.9 nM. SIAIS001 induces ALK protein degradation via the ubiquitin-proteasome system. SIAIS001 induces G1/S phase cell cycle arrest and inhibits proliferation of cancer cells. SIAIS001 can be used for the research of anaplastic large-cell lymphomas.
(Pink: Anaplastic lymphoma kinase (ALK) ligand (HY-13011); Blue: Cereblon ligand (HY-138793); Black: linker).
For research use only. We do not sell to patients.
- CAS No.: 2570251-63-5
- Formula: C48H51N7O4
- Molecular Weight:789.96
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
All PROTACs Isoforms
More
Biological Activity
|
Cereblon |
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| SR | IC50 |
0.9 nM
Compound: C26; SIAIS001
|
Antiproliferative activity against ALK positive human SR cells
Antiproliferative activity against ALK positive human SR cells
|
[PMID: 33751979] |
SIAIS001 (0.05-500 nM) potently degrades ALK protein via the ubiquitin-proteasome system in SR (NPM-ALK fusion) anaplastic large-cell lymphoma cells, with a DC50 of 3.9 nM and a maximum degradation of 70.3%[1].
SIAIS001 inhibits SR (NPM-ALK fusion) cell proliferation with an IC50 of 0.9 nM[1].
SIAIS001 (0.05-500 nM) inhibits ALK downstream signaling in SR (NPM-ALK fusion) anaplastic large-cell lymphoma cells, reducing phosphorylated ALK and phosphorylated STAT3[1].
SIAIS001 potently inhibits wild-type ALK kinase activity with an IC50 of 3.3 nM and inhibits ALKG1202R mutant kinase activity with an IC50 of 94.6 nM[1].
SIAIS001 (100 nM; 24 h) promotes G1/S phase cell cycle arrest in SR (NPM-ALK fusion) anaplastic large-cell lymphoma cells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:SR (NPM-ALK fusion) anaplastic large-cell lymphoma cells
-
Concentration:100 nM
-
Incubation Time:24 h
-
Result:Induced G1/S cell cycle arrest in SR cells.
Reduced the percentage of cells in S phase to a level significantly lower than that observed with Alectinib (HY-13011) treatment, indicating stronger G1/S arrest than Alectinib.
Chemical Information
-
CAS No. 2570251-63-5
-
Molecular Weight 789.96
-
Formula C48H51N7O4
-
SMILES
N#CC1=CC(NC2=C3C(C4=C(C2(C)C)C=C(N5CCC(CC5)N6CCN(CCCC#CC7=CC=CC8=C7CN(C9C(NC(CC9)=O)=O)C8=O)CC6)C(CC)=C4)=O)=C3C=C1
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)